Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Unsupervised Flow Cytometry Analysis: Application to Minimal Residual Disease Detection in a Cohort of 40 Acute Myeloblastic Leukemia Patients with Molecular Markers

Nicolas Lechevalier, PharmD, Jean-Philippe Vial, MD, Francis Lacombe, MDPhD, Pierre-Yves Dumas, MDPhD, Audrey Bidet, PharmD, Thibaut Leguay, MD, Francois Vergez, DVM, PhD, Arnaud Pigneux, MD PhD, Marie C Béné, PharmSciD, PhD

Blood (2020) 136 (Supplement 1): 30.

https://doi.org/10.1182/blood-2020-141199

Published: 2020

Journal Articles

Prognostic Value of Lymphopenia and Lymphocytosis after Peripheral Blood Haplo-Identical Stem Cell Transplantation

Yannick LE Bris, PharmD, Thierry Guillaume, MD PhD, Camille Debord, PharmD, Pierre Peterlin, Soraya Wuilleme, PharmD, PhD, Céline Bressollette, MD PhD, Amandine Le Bourgeois, MD, Alice Garnier, MD, Aurélie Fantou, PharmD, Marie Audrain, MD PhD, Audrey Ménard, Nelly Robillard, PhD, Marion Eveillard, Steven Le Gouill, Berthe Marie Imbert, PharmD, PhD, Marie C Bene, PharmSciD, PhD, Patrice Chevallier, MD

Blood (2019) 134 (Supplement_1): 3319.

https://doi.org/10.1182/blood-2019-122093

Published: 2019

Journal Articles

New Concepts of Flow Cytometry Analysis in Oncohematology: Application to Diagnosis and Follow up (Minimal Residual Disease) in AML, ALL and MDS

Francis Lacombe, MD PhD, Benoït Dupont, Nicolas Lechevalier, PharmD, Jean-Philippe Vial, MD, Arnaud Pigneux, MD PhD, Marie C Bene, PharmSciD, PhD

Blood (2017) 130 (Supplement 1): 1421.

https://doi.org/10.1182/blood.V130.Suppl_1.1421.1421

Published: 2017

Journal Articles

Addition of Lomustine in the Treatment of Elderly Patients with Acute Myeloblastic Leukemia Improves Survival with Acceptably Increased Infectious Toxicity. a Filo Study

Blood (2017) 130 (Supplement 1): 2587.

https://doi.org/10.1182/blood.V130.Suppl_1.2587.2587

Published: 2017

Journal Articles

High-Resolution Whole-Genome Copy Number Profiling Identifies High-Risk and Low-Risk Patients with Mantle Cell Lymphoma, a Result of the Lyma-Genomic Project Conducted on Behalf the Lysa Group

Yannick Le Bris, PharmD, Florence Magrangeas, Olivier Hermine, MD PhD, David Chiron, PhD, Danielle Canioni, Anne Moreau, MD, Marie C Bene, PharmSciD, PhD, Loic Campion, Stephane Minvielle, Steven Le Gouill, MD PhD

Blood (2016) 128 (22): 1745.

https://doi.org/10.1182/blood.V128.22.1745.1745

Published: 2016

Journal Articles

Polymorphonuclears Display a New Type of Abnormal Cytologic Granules (Chediak Higashi-Like) in a Very Rare Syndrome Linked to a Biallelic Defect of WDR81

Marion Eveillard, PharmD, PhD, Myriam Chevalier, Thomas Besnard, Benjamin Cogne, Alice Kuster, Stephane Bezieau, Marie C Bene, PharmSciD, PhD, Claire Beneteau

Blood (2016) 128 (22): 1331.

https://doi.org/10.1182/blood.V128.22.1331.1331

Published: 2016

Journal Articles

CD38 Expression in B-Lineage Acute Lymphoblastic Leukemia, a Possible Target for Immunotherapy

Marion Eveillard, PharmD, PhD, Victor Floc'h, Nelly Robillard, PhD, Camille Debord, Soraya Wuilleme, PharmD, PhD, Richard Garand, Fanny Rialland, MD, Caroline Thomas, Pierre Peterlin, MD, Thierry Guillaume, MD PhD, Philippe Moreau, Patrice Chevallier, MD PhD, Marie C Bene, PharmSciD, PhD

Blood (2016) 128 (22): 5268.

https://doi.org/10.1182/blood.V128.22.5268.5268

Published: 2016

Journal Articles

Comparative Value of the Assessment of Minimal Residual Disease in Peripheral Blood at Days 8 and 15 By Flow Cytometry in Childhood Acute Lymphoblastic Leukemia

Marie Loosveld, MD PhD, Vanessa Nivaggioni, Isabelle Arnoux, Denis Bernot, Chantal Fossat, MD, Gerard Michel, MD, Marie C Bene, PharmSciD, PhD, Marion Eveillard, PharmD, PhD

Blood (2016) 128 (22): 5270.

https://doi.org/10.1182/blood.V128.22.5270.5270

Published: 2016

Journal Articles

Interest of the XN-10 ® Analyzer to Screen for Myelodysplastic Syndromes on Complete Blood Count (CBC) Especially with Hemoglobin Levels and Neut-WX

Robin Boutault, Sebastien Tremblais, Mathilde De Oliveira Lopes, Pierre Peterlin, MD, Yannick Le Bris, PharmD, Catherine Godon, MD, Olivier Theisen, MD, Marie C Bene, PharmSciD, PhD, Marion Eveillard, PharmD, PhD

Blood (2016) 128 (22): 5518.

https://doi.org/10.1182/blood.V128.22.5518.5518

Published: 2016

Journal Articles

Engraftment of Donor Cells after Allogeneic Stem Cell Transplantation: Comparison and Impact of Chimerism in Whole Blood and Peripheral CD3+ T-Cells

Yannick Le Bris, PharmD, Berger Florian, Audrey Menard, Thierry Guillaume, MD PhD, Pierre Peterlin, MD, Alice Garnier, MD, Laurence Lode, PharmD, Laetitia Aubert, Marie C Boursier, Véronique Chenais, Fabienne Perrault, Amandine Sebie, Philippe Moreau, Marie C Bene, PharmSciD, PhD, Patrice Chevallier, MD PhD

Blood (2016) 128 (22): 5866.

https://doi.org/10.1182/blood.V128.22.5866.5866

Published: 2016

Journal Articles

Post-Transplant Cyclophosphamide (PTCY) Versus Anti-Thymoglobulin (ATG) As Part of the Gvhd Prophylaxis for Fludarabine/Clofarabine/Busulfan Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT): Influence on Early Outcomes

Alice Garnier, MD, Thierry Guillaume, MD, Pierre Peterlin, MD, Beatrice Mahe, MD, Viviane Dubruille, MD, Nicolas Blin, MD, Maud Voldoire, MD, Thomas Gastinne, MD, Cyrille Touzeau, MD PhD, Steven Le Gouill, MD PhD, Yannick Le Bris, PharmD, Marion Eveillard, PharmD, Marie C Bene, PharmSciD, PhD, Marina Illiaquer, PharmD, Berthe marie Imbert, Philippe Moreau, MD PhD, Patrice Chevallier, MD PhD

Blood (2015) 126 (23): 4339.

https://doi.org/10.1182/blood.V126.23.4339.4339

Published: 2015

Journal Articles

First Line Chronic Lymphocytic Leukemia Immunochemotherapy for the Elderly Patients over 79 Years Is Feasible, and Achieves Good Results: A Filo Retrospective Study

Blood (2015) 126 (23): 4170.

https://doi.org/10.1182/blood.V126.23.4170.4170

Published: 2015

Journal Articles

Expansion of T or B Lymphocytes after Unrelated Cord Blood (UCB) Allogeneic Stem Cell Transplantation in Adults Correlates with CMV Reactivation and Is Associated with a Better Outcome

Yannick Le Bris, PharmD, Thierry Guillaume, MD PhD, Marina Iliaquer, PharmD, Jerome Martin, PharmD, PhD, Pierre Peterlin, MD, Audrey Menard, Marion Eveillard, PharmD, Soraya Wuilleme, PharmD, PhD, Nelly Robillard, PhD, Jacques Delaunay, MD, Mohamad Mohty, MD PhD, Alice Garnier, MD, Philippe Moreau, MD PhD, Marie C Bene, PharmSciD, PhD, Patrice Chevallier, MD PhD

Blood (2015) 126 (23): 1947.

https://doi.org/10.1182/blood.V126.23.1947.1947

Published: 2015

Journal Articles

Allogeneic Stem Cell Transplantation for Primary or Secondary Myelofibrosis: A Retrospective Intent-to-Treat Analysis and Impact of Mutational Status and JAK1/2 Inhibitor Ruxolitinib Prescription in Patients Who Cannot Proceed to Transplantation

Elsa Lestang, Pierre Peterlin, MD, Yannick Le Bris, PharmD, Jacques Delaunay, MD, Viviane Dubruille, MD, Nicolas Blin, MD, Beatrice Mahe, MD, Thomas Gastinne, MD, Alice Garnier, MD, Cyrille Touzeau, MD PhD, Maud Voldoire, MD, Herve Maisonneuve, MD, Marie C Bene, PharmSciD, PhD, Steven Le Gouill, MD PhD, Noel Milpied, Mohamad Mohty, MD PhD, Philippe Moreau, MD PhD, Thierry Guillaume, MD PhD, Patrice Chevallier, MD PhD

Blood (2015) 126 (23): 3218.

https://doi.org/10.1182/blood.V126.23.3218.3218

Published: 2015

Journal Articles

Safety and Long-Term Efficacy of Maintenance Therapy with Alternating Azacytidine (AZA) and Lenalidomide (Len) Cycles in Elderly (≥ 60) Fit Patients (Pts) with Poor Prognosis AML in First Complete Remission (CR) After LIA Induction. A Phase II Multicentric GOELAMS Trial

Blood (2015) 126 (23): 3787.

https://doi.org/10.1182/blood.V126.23.3787.3787

Published: 2015

Journal Articles

Addition of Lomustine (CCNU) to Induction and Post-Remission Chemotherapy for Fit Elderly AML Patients without Unfavorable Cytogenetics: Results of the Lamsa-2007 Goelams Trial

Blood (2015) 126 (23): 3736.

https://doi.org/10.1182/blood.V126.23.3736.3736

Published: 2015

Journal Articles

Relative Stability Of Plasma Cells Immunophenotype In Multiple Myeloma Over Time

Benoit Tessoulin, Steven Legouill, MD PhD, Marion Eveillard, Nelly Robillard, Soraya Wuilleme, Thomas Gastinne, MD, Cyrille Touzeau, MD, Catherine Pellat-Deceunynck, PhD, Marie C Bene, PharmSciD, PhD, Philippe Moreau, MD

Blood (2013) 122 (21): 1885.

https://doi.org/10.1182/blood.V122.21.1885.1885

Published: 2013

Journal Articles

Cereblon (CRBN) Splicing Could Influence Response To IMiDs : A New PCR Strategy to Easily Detect and Semi-Quantify Loss Of The IMiDs Binding Domain

Blood (2013) 122 (21): 3107.

https://doi.org/10.1182/blood.V122.21.3107.3107

Published: 2013

Journal Articles

Assessment Of Minimal Residual Disease In Acute Myeloblastic Leukemia In Multiparameter Flow Cytometry

Blood (2013) 122 (21): 2613.

https://doi.org/10.1182/blood.V122.21.2613.2613

Published: 2013

Journal Articles

Differential Effects Of Triggering Via Toll Like Receptors In Stable Or Aggressive Chronic Lymphocytic Leukemia

Min Chen, MD, PhD, Claude Capron, PharmD, PhD, Gilbert Faure, MD, PhD, Marc Maynadie, MD, PhD, Pierre Feugier, MD, PhD, Marcelo de Carvalho Bittencourt, MD, PhD, Marie C Béné, PharmSciD, PhD

Blood (2013) 122 (21): 5296.

https://doi.org/10.1182/blood.V122.21.5296.5296

Published: 2013

NARROW

Unsupervised Flow Cytometry Analysis: Application to Minimal Residual Disease Detection in a Cohort of 40 Acute Myeloblastic Leukemia Patients with Molecular Markers

Prognostic Value of Lymphopenia and Lymphocytosis after Peripheral Blood Haplo-Identical Stem Cell Transplantation

New Concepts of Flow Cytometry Analysis in Oncohematology: Application to Diagnosis and Follow up (Minimal Residual Disease) in AML, ALL and MDS

Addition of Lomustine in the Treatment of Elderly Patients with Acute Myeloblastic Leukemia Improves Survival with Acceptably Increased Infectious Toxicity. a Filo Study

High-Resolution Whole-Genome Copy Number Profiling Identifies High-Risk and Low-Risk Patients with Mantle Cell Lymphoma, a Result of the Lyma-Genomic Project Conducted on Behalf the Lysa Group

Polymorphonuclears Display a New Type of Abnormal Cytologic Granules (Chediak Higashi-Like) in a Very Rare Syndrome Linked to a Biallelic Defect of WDR81

CD38 Expression in B-Lineage Acute Lymphoblastic Leukemia, a Possible Target for Immunotherapy

Comparative Value of the Assessment of Minimal Residual Disease in Peripheral Blood at Days 8 and 15 By Flow Cytometry in Childhood Acute Lymphoblastic Leukemia

Interest of the XN-10 ® Analyzer to Screen for Myelodysplastic Syndromes on Complete Blood Count (CBC) Especially with Hemoglobin Levels and Neut-WX

Engraftment of Donor Cells after Allogeneic Stem Cell Transplantation: Comparison and Impact of Chimerism in Whole Blood and Peripheral CD3+ T-Cells

Post-Transplant Cyclophosphamide (PTCY) Versus Anti-Thymoglobulin (ATG) As Part of the Gvhd Prophylaxis for Fludarabine/Clofarabine/Busulfan Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT): Influence on Early Outcomes

First Line Chronic Lymphocytic Leukemia Immunochemotherapy for the Elderly Patients over 79 Years Is Feasible, and Achieves Good Results: A Filo Retrospective Study

Expansion of T or B Lymphocytes after Unrelated Cord Blood (UCB) Allogeneic Stem Cell Transplantation in Adults Correlates with CMV Reactivation and Is Associated with a Better Outcome

Allogeneic Stem Cell Transplantation for Primary or Secondary Myelofibrosis: A Retrospective Intent-to-Treat Analysis and Impact of Mutational Status and JAK1/2 Inhibitor Ruxolitinib Prescription in Patients Who Cannot Proceed to Transplantation

Safety and Long-Term Efficacy of Maintenance Therapy with Alternating Azacytidine (AZA) and Lenalidomide (Len) Cycles in Elderly (≥ 60) Fit Patients (Pts) with Poor Prognosis AML in First Complete Remission (CR) After LIA Induction. A Phase II Multicentric GOELAMS Trial

Addition of Lomustine (CCNU) to Induction and Post-Remission Chemotherapy for Fit Elderly AML Patients without Unfavorable Cytogenetics: Results of the Lamsa-2007 Goelams Trial

Relative Stability Of Plasma Cells Immunophenotype In Multiple Myeloma Over Time

Cereblon (CRBN) Splicing Could Influence Response To IMiDs : A New PCR Strategy to Easily Detect and Semi-Quantify Loss Of The IMiDs Binding Domain

Assessment Of Minimal Residual Disease In Acute Myeloblastic Leukemia In Multiparameter Flow Cytometry

Differential Effects Of Triggering Via Toll Like Receptors In Stable Or Aggressive Chronic Lymphocytic Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only